Innovation and Regulation

Francis discusses the delicate balance between innovation and regulatory challenges in the biotech sector. He emphasizes the importance of aligning mission with business strategy, which simplifies tough decisions regarding risk and investment. The conversation also touches on the complexities of reacquiring Grail and the broader implications for the future of health technology.